| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $69.3M | +107.1% |
| SG&A Expense | $21.9M | +55.7% |
| Operating Income | -$91.1M | -91.9% |
| Pre-tax Income | -$76.3M | -63.0% |
| Income Tax | $99K | — |
| Net Income | -$76.4M | -63.2% |
| EPS (Basic) | -$3.42 | +92.4% |
| EPS (Diluted) | -$3.42 | +92.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $360.4M | +85.2% |
| Current Assets | $365.7M | +84.2% |
| Total Assets | $368.0M | +83.8% |
| Current Liabilities | $21.4M | -5.0% |
| Total Liabilities | $22.9M | -3.1% |
| Stockholders' Equity | $345.1M | +95.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.5M | -73.9% |
| Capital Expenditures | $89K | -41.1% |
| Investing Cash Flow | -$89K | +41.1% |
| Financing Cash Flow | $239.4M | +60.7% |
| Free Cash Flow | -$73.6M | -73.5% |